In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Ascension Orthopedics' Fate May Rest on the Shoulder

Executive Summary

After more than a decade of crafting small bone orthopedic implants from its innovative PyroCarbon biomaterial, Ascension is hoping to reach its full potential by obtaining regulatory approval for a line of carbon shoulder replacement systems that might change the way the joint is treated.

You may also be interested in...

Orthopedics M&A Moving From Center To Extremities

For the past few years, medical device VCs have slowly steered their capital away from spine start-ups and towards other opportunities in orthopedics, like extremities. Now, after years of near zero acquisition activity, strategic acquirers made not one but two significant acquisitions of extremities companies, creating a bit of a race to acquire a share of this small, but growing market.

Is Wright Medical Back on Track?

Wright Medical hasn’t enjoyed the smoothest ride over the past 15 years, a stretch that included a spin-out, debt problems, and a buyout, as well as an IPO. All the while, though, the company has proven to be an innovator in the large joints industries and now—under new CEO Gary Henley—it is establishing itself as a force in the extremities and biomaterials markets.

STAR Becomes First Mobile-Bearing Ankle Approved In U.S.

Small Bone Innovations (SBi) hopes its STAR total ankle replacement system will be the catalyst for a shift in ankle procedures away from the fusion surgery standard toward a market dominated by joint replacement. But the barriers in the still-limited ankle replacement space are not trivial

Related Content


Related Companies

Related Deals

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts